| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 6.44e-07 | 16 | 89 | 4 | GO:0004697 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.44e-07 | 16 | 89 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 NTN3 ZNF780B ZNF558 NR4A2 ZBTB5 ZNF74 NTN1 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 NOTCH2 NR1D2 ZNF77 | 7.39e-07 | 1412 | 89 | 21 | GO:0000981 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.08e-06 | 21 | 89 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 NTN3 ZNF780B ZNF558 NR4A2 ZBTB5 ZNF74 NTN1 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 NR1D2 ZNF77 | 4.99e-06 | 1459 | 89 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | integrin binding | 1.33e-05 | 175 | 89 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | calcium,diacylglycerol-dependent serine/threonine kinase activity | 1.96e-05 | 2 | 89 | 2 | GO:0004698 | |
| GeneOntologyMolecularFunction | histone H3T6 kinase activity | 1.96e-05 | 2 | 89 | 2 | GO:0035403 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.11e-05 | 188 | 89 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | zinc ion binding | SETDB2 USP22 ADAMTS9 RCHY1 NR4A2 HLTF KMT2A PRKCA PRKCB PRKCG USP16 ZKSCAN5 RPH3A NR1D2 | 3.79e-05 | 891 | 89 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | histone modifying activity | 7.39e-05 | 229 | 89 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 USP6 FBLN1 STIM2 FBN1 LRP2 LTBP1 SPARCL1 LRP1B LDLR RPH3A NOTCH2 | 1.19e-04 | 749 | 89 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF597 ZNF23 ZNF728 ZNF175 NTN3 ZNF780B NR4A2 ZNF74 NTN1 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 NOTCH2 NR1D2 | 1.41e-04 | 1271 | 89 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | transition metal ion binding | SETDB2 USP22 ADAMTS9 RCHY1 NR4A2 HLTF KMT2A PRKCA PRKCB PRKCG MUC2 USP16 ZKSCAN5 RPH3A NR1D2 | 2.29e-04 | 1189 | 89 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 2.91e-04 | 6 | 89 | 2 | GO:0140950 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF597 ZNF23 ZNF728 ZNF175 NTN3 ZNF780B NR4A2 ZNF74 NTN1 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 NR1D2 | 3.72e-04 | 1244 | 89 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 5.41e-04 | 8 | 89 | 2 | GO:0140934 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.67e-04 | 85 | 89 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 8.64e-04 | 10 | 89 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 1.26e-03 | 12 | 89 | 2 | GO:0140996 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.69e-03 | 114 | 89 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.04e-03 | 120 | 89 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | phosphate ion binding | 2.26e-03 | 16 | 89 | 2 | GO:0042301 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 2.30e-03 | 124 | 89 | 4 | GO:0101005 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 2.87e-03 | 18 | 89 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 3.30e-03 | 137 | 89 | 4 | GO:0019783 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 4.43e-06 | 8 | 90 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | secondary palate development | 5.51e-06 | 27 | 90 | 4 | GO:0062009 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.29e-05 | 11 | 90 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.72e-05 | 124 | 90 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 2.23e-05 | 13 | 90 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 2.23e-05 | 13 | 90 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.35e-05 | 131 | 90 | 6 | GO:0030510 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 2.63e-05 | 80 | 90 | 5 | GO:0030514 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | LPAR3 SYNE1 NTN3 NR4A2 LRP2 LAMA2 LAMB2 PRKCA NTN1 PRKCQ ADAM10 NOTCH2 | 9.71e-05 | 748 | 90 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.12e-04 | 4 | 90 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | Langerhans cell differentiation | 1.12e-04 | 4 | 90 | 2 | GO:0061520 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.31e-04 | 112 | 90 | 5 | GO:0045185 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.41e-04 | 445 | 90 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | circulatory system development | CER1 SETDB2 FBN1 THSD7A ADAMTS9 SYNE1 WNT11 LRP2 PRKCA PRKCB LTBP1 ZNF418 ADAM12 ADAM10 LDLR ITGB8 NOTCH2 | 1.46e-04 | 1442 | 90 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | axonogenesis | 1.79e-04 | 566 | 90 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | LPAR3 SYNE1 NTN3 NR4A2 LRP2 LAMA2 LAMB2 PRKCA NTN1 PRKCQ ADAM10 NOTCH2 | 1.86e-04 | 802 | 90 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.87e-04 | 5 | 90 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | sequestering of BMP in extracellular matrix | 1.87e-04 | 5 | 90 | 2 | GO:0035582 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.25e-04 | 197 | 90 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | LPAR3 SYNE1 NTN3 NR4A2 LRP2 LAMA2 LAMB2 PRKCA NTN1 PRKCQ ADAM10 NOTCH2 | 2.26e-04 | 819 | 90 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 2.43e-04 | 28 | 90 | 3 | GO:0043011 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | LPAR3 SYNE1 NTN3 NR4A2 LRP2 LAMA2 LAMB2 PRKCA NTN1 PRKCQ ADAM10 NOTCH2 | 2.44e-04 | 826 | 90 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon guidance | 2.51e-04 | 285 | 90 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.55e-04 | 482 | 90 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.56e-04 | 286 | 90 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | artery development | 2.93e-04 | 133 | 90 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | tube development | CER1 SETDB2 FBN1 THSD7A ADAMTS9 INSC WNT11 LRP2 PRKCA PRKCB NTN1 ADAM12 LDLR ITGB6 ITGB8 NOTCH2 | 3.40e-04 | 1402 | 90 | 16 | GO:0035295 |
| GeneOntologyBiologicalProcess | response to BMP | 3.60e-04 | 215 | 90 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 3.60e-04 | 215 | 90 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.87e-04 | 218 | 90 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.90e-04 | 7 | 90 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.40e-04 | 412 | 90 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | axon development | 4.85e-04 | 642 | 90 | 10 | GO:0061564 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 5.09e-04 | 150 | 90 | 5 | GO:0090288 | |
| GeneOntologyBiologicalProcess | mitotic nuclear membrane disassembly | 5.18e-04 | 8 | 90 | 2 | GO:0007077 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 6.84e-04 | 337 | 90 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta production | 7.06e-04 | 40 | 90 | 3 | GO:0071604 | |
| GeneOntologyBiologicalProcess | regulation of insulin receptor signaling pathway | 7.07e-04 | 92 | 90 | 4 | GO:0046626 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 7.07e-04 | 92 | 90 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.12e-04 | 347 | 90 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 8.28e-04 | 10 | 90 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | hard palate development | 8.28e-04 | 10 | 90 | 2 | GO:0060022 | |
| GeneOntologyBiologicalProcess | podocyte development | 8.28e-04 | 10 | 90 | 2 | GO:0072015 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS10 FBLN1 FBN1 ZAN ADAMTS9 NTN3 WNT11 LAMA2 LAMB2 NTN1 LTBP1 SPARCL1 ADAMTSL3 ADAM10 MUC2 USH2A | 2.98e-08 | 656 | 93 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS10 FBLN1 FBN1 ZAN ADAMTS9 NTN3 WNT11 LAMA2 LAMB2 NTN1 LTBP1 SPARCL1 ADAMTSL3 ADAM10 MUC2 USH2A | 3.11e-08 | 658 | 93 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 FBLN1 FBN1 ADAMTS9 NTN3 LAMA2 LAMB2 NTN1 LTBP1 SPARCL1 ADAM10 MUC2 USH2A | 6.30e-07 | 530 | 93 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.21e-06 | 122 | 93 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | microfibril | 2.36e-05 | 13 | 93 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.39e-04 | 59 | 93 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | calyx of Held | 5.47e-04 | 36 | 93 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 1.35e-03 | 49 | 93 | 3 | GO:0099523 | |
| Domain | EGF_1 | JAG2 FBLN1 FBN1 ZAN ATRNL1 NTN3 LRP2 LAMA2 LAMB2 NTN1 LTBP1 ADAM12 USH2A LRP1B LDLR ITGB6 ITGB8 NOTCH2 | 4.35e-16 | 255 | 93 | 18 | PS00022 |
| Domain | EGF-like_CS | JAG2 FBLN1 FBN1 ZAN ATRNL1 NTN3 LRP2 LAMA2 LAMB2 NTN1 LTBP1 ADAM12 LRP1B LDLR ITGB6 ITGB8 NOTCH2 SORL1 | 6.56e-16 | 261 | 93 | 18 | IPR013032 |
| Domain | EGF_2 | JAG2 FBLN1 FBN1 ZAN ATRNL1 NTN3 LRP2 LAMA2 LAMB2 NTN1 LTBP1 ADAM12 LRP1B LDLR ITGB6 ITGB8 NOTCH2 SORL1 | 8.57e-16 | 265 | 93 | 18 | PS01186 |
| Domain | EGF | JAG2 FBLN1 FBN1 ZAN ATRNL1 LRP2 LAMA2 LAMB2 LTBP1 LRP1B LDLR ITGB8 NOTCH2 SORL1 | 1.04e-11 | 235 | 93 | 14 | SM00181 |
| Domain | EGF-like_dom | JAG2 FBLN1 FBN1 ZAN ATRNL1 LRP2 LAMA2 LAMB2 LTBP1 ADAM12 LRP1B LDLR NOTCH2 SORL1 | 2.26e-11 | 249 | 93 | 14 | IPR000742 |
| Domain | KRAB | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZNF780B ZNF558 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 2.61e-10 | 358 | 93 | 15 | PS50805 |
| Domain | Growth_fac_rcpt_ | JAG2 FBLN1 FBN1 CRIM1 NTN3 LRP2 LAMB2 LTBP1 LRP1B LDLR NOTCH2 | 3.27e-10 | 156 | 93 | 11 | IPR009030 |
| Domain | KRAB | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZNF780B ZNF558 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 3.97e-10 | 369 | 93 | 15 | SM00349 |
| Domain | KRAB | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZNF780B ZNF558 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 4.12e-10 | 370 | 93 | 15 | IPR001909 |
| Domain | EGF_3 | JAG2 FBLN1 FBN1 ZAN ATRNL1 LRP2 LTBP1 ADAM12 LRP1B LDLR NOTCH2 SORL1 | 2.02e-09 | 235 | 93 | 12 | PS50026 |
| Domain | KRAB | ZNF597 ZNF20 ZNF728 ZNF175 ZNF780B ZNF558 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 2.65e-09 | 358 | 93 | 14 | PF01352 |
| Domain | zf-C2H2_6 | ZNF597 ZNF20 ZNF728 ZFP64 ZNF780B ZNF558 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 5.20e-09 | 314 | 93 | 13 | PF13912 |
| Domain | EGF_LAM_2 | 6.98e-09 | 30 | 93 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 6.98e-09 | 30 | 93 | 6 | PS01248 | |
| Domain | EGF_CA | 1.07e-08 | 86 | 93 | 8 | PF07645 | |
| Domain | Laminin_N | 1.15e-08 | 16 | 93 | 5 | IPR008211 | |
| Domain | LAMININ_NTER | 1.15e-08 | 16 | 93 | 5 | PS51117 | |
| Domain | Laminin_N | 1.15e-08 | 16 | 93 | 5 | PF00055 | |
| Domain | LamNT | 1.15e-08 | 16 | 93 | 5 | SM00136 | |
| Domain | EGF_Lam | 1.87e-08 | 35 | 93 | 6 | SM00180 | |
| Domain | EGF_extracell | 1.88e-08 | 60 | 93 | 7 | IPR013111 | |
| Domain | EGF_2 | 1.88e-08 | 60 | 93 | 7 | PF07974 | |
| Domain | EGF_Ca-bd_CS | 2.80e-08 | 97 | 93 | 8 | IPR018097 | |
| Domain | Laminin_EGF | 3.14e-08 | 38 | 93 | 6 | IPR002049 | |
| Domain | EGF_CA | 3.29e-08 | 99 | 93 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.56e-08 | 100 | 93 | 8 | PS00010 | |
| Domain | - | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 3.63e-08 | 679 | 93 | 17 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZC3H7B ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 4.27e-08 | 775 | 93 | 18 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZC3H7B ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 4.44e-08 | 777 | 93 | 18 | PS00028 |
| Domain | zf-C2H2 | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 4.88e-08 | 693 | 93 | 17 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 4.98e-08 | 694 | 93 | 17 | IPR013087 |
| Domain | DAG/PE-bd | 5.25e-08 | 21 | 93 | 5 | IPR020454 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.63e-08 | 106 | 93 | 8 | IPR000152 | |
| Domain | Znf_C2H2-like | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZC3H7B ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 6.39e-08 | 796 | 93 | 18 | IPR015880 |
| Domain | Znf_C2H2 | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZC3H7B ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 7.57e-08 | 805 | 93 | 18 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZC3H7B ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 8.01e-08 | 808 | 93 | 18 | SM00355 |
| Domain | Protein_kinase_C_a/b/g | 1.20e-07 | 3 | 93 | 3 | IPR014375 | |
| Domain | cEGF | 1.66e-07 | 26 | 93 | 5 | IPR026823 | |
| Domain | cEGF | 1.66e-07 | 26 | 93 | 5 | PF12662 | |
| Domain | EGF_CA | 1.68e-07 | 122 | 93 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.91e-07 | 124 | 93 | 8 | IPR001881 | |
| Domain | Ldl_recept_b | 5.55e-07 | 14 | 93 | 4 | PF00058 | |
| Domain | LDLRB | 5.55e-07 | 14 | 93 | 4 | PS51120 | |
| Domain | LY | 7.54e-07 | 15 | 93 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.54e-07 | 15 | 93 | 4 | IPR000033 | |
| Domain | Laminin_EGF | 7.92e-07 | 35 | 93 | 5 | PF00053 | |
| Domain | VWC_out | 2.11e-06 | 19 | 93 | 4 | SM00215 | |
| Domain | C1_1 | 9.37e-06 | 57 | 93 | 5 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 1.66e-05 | 64 | 93 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.66e-05 | 64 | 93 | 5 | PS50081 | |
| Domain | C1 | 1.79e-05 | 65 | 93 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 1.93e-05 | 66 | 93 | 5 | IPR002219 | |
| Domain | VWFC_1 | 3.00e-05 | 36 | 93 | 4 | PS01208 | |
| Domain | Pkinase_C | 3.35e-05 | 37 | 93 | 4 | IPR017892 | |
| Domain | VWC | 3.74e-05 | 38 | 93 | 4 | SM00214 | |
| Domain | VWFC_2 | 3.74e-05 | 38 | 93 | 4 | PS50184 | |
| Domain | EGF | 3.95e-05 | 126 | 93 | 6 | PF00008 | |
| Domain | Peptidase_M12B_N | 4.15e-05 | 39 | 93 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 4.15e-05 | 39 | 93 | 4 | PF01562 | |
| Domain | - | 4.15e-05 | 39 | 93 | 4 | 2.120.10.30 | |
| Domain | TIL_dom | 4.18e-05 | 14 | 93 | 3 | IPR002919 | |
| Domain | DISINTEGRIN_1 | 4.59e-05 | 40 | 93 | 4 | PS00427 | |
| Domain | LDLR_class-A_CS | 4.59e-05 | 40 | 93 | 4 | IPR023415 | |
| Domain | Reprolysin | 4.59e-05 | 40 | 93 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 4.59e-05 | 40 | 93 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.59e-05 | 40 | 93 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 4.59e-05 | 40 | 93 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 5.07e-05 | 41 | 93 | 4 | IPR001762 | |
| Domain | Pkinase_C | 5.58e-05 | 42 | 93 | 4 | PF00433 | |
| Domain | VWF_dom | 5.58e-05 | 42 | 93 | 4 | IPR001007 | |
| Domain | Ldl_recept_a | 7.34e-05 | 45 | 93 | 4 | PF00057 | |
| Domain | - | 8.01e-05 | 46 | 93 | 4 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 8.01e-05 | 46 | 93 | 4 | IPR011042 | |
| Domain | LDLRA_1 | 9.48e-05 | 48 | 93 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.03e-04 | 49 | 93 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.03e-04 | 49 | 93 | 4 | IPR002172 | |
| Domain | LDLa | 1.03e-04 | 49 | 93 | 4 | SM00192 | |
| Domain | AGC-kinase_C | 1.74e-04 | 56 | 93 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.74e-04 | 56 | 93 | 4 | PS51285 | |
| Domain | S_TK_X | 1.74e-04 | 56 | 93 | 4 | SM00133 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.24e-04 | 24 | 93 | 3 | IPR013273 | |
| Domain | TSP_1 | 2.74e-04 | 63 | 93 | 4 | PF00090 | |
| Domain | TSP1 | 3.09e-04 | 65 | 93 | 4 | SM00209 | |
| Domain | TSP1_rpt | 3.09e-04 | 65 | 93 | 4 | IPR000884 | |
| Domain | TSP1 | 3.09e-04 | 65 | 93 | 4 | PS50092 | |
| Domain | USP_CS | 3.28e-04 | 66 | 93 | 4 | IPR018200 | |
| Domain | USP_1 | 4.11e-04 | 70 | 93 | 4 | PS00972 | |
| Domain | UCH | 4.34e-04 | 71 | 93 | 4 | PF00443 | |
| Domain | USP_2 | 4.34e-04 | 71 | 93 | 4 | PS00973 | |
| Domain | USP_3 | 4.58e-04 | 72 | 93 | 4 | PS50235 | |
| Domain | USP_dom | 4.58e-04 | 72 | 93 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 4.58e-04 | 72 | 93 | 4 | IPR001394 | |
| Domain | TLV_coat | 5.07e-04 | 7 | 93 | 2 | PF00429 | |
| Domain | TB | 5.07e-04 | 7 | 93 | 2 | PF00683 | |
| Domain | Integrin_beta | 6.74e-04 | 8 | 93 | 2 | PF00362 | |
| Domain | TLV/ENV_coat_polyprotein | 6.74e-04 | 8 | 93 | 2 | IPR018154 | |
| Domain | - | 6.74e-04 | 8 | 93 | 2 | 3.90.290.10 | |
| Domain | INB | 6.74e-04 | 8 | 93 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 6.74e-04 | 8 | 93 | 2 | IPR002369 | |
| Domain | MetalloPept_cat_dom | 7.15e-04 | 81 | 93 | 4 | IPR024079 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBLN1 FBN1 ADAMTS9 LAMA2 LAMB2 PRKCA LTBP1 ADAM12 ADAM10 ITGB6 ITGB8 | 5.65e-07 | 300 | 76 | 11 | M610 |
| Pathway | WP_WNT_SIGNALING | 8.82e-07 | 61 | 76 | 6 | MM15893 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 1.49e-06 | 5 | 76 | 3 | M26920 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.52e-06 | 37 | 76 | 5 | M27134 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.27e-06 | 118 | 76 | 7 | M39852 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.67e-06 | 44 | 76 | 5 | M26969 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 8.27e-06 | 8 | 76 | 3 | M47555 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 8.27e-06 | 8 | 76 | 3 | M47479 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.70e-05 | 101 | 76 | 6 | M39387 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.70e-05 | 101 | 76 | 6 | MM15829 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 1.76e-05 | 10 | 76 | 3 | M47644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 2.41e-05 | 11 | 76 | 3 | M47637 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.50e-05 | 32 | 76 | 4 | MM14854 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.19e-05 | 68 | 76 | 5 | M27303 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 3.20e-05 | 12 | 76 | 3 | M47597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 3.20e-05 | 12 | 76 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 3.20e-05 | 12 | 76 | 3 | M47628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.14e-05 | 13 | 76 | 3 | M47656 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 5.01e-05 | 38 | 76 | 4 | MM14874 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 5.25e-05 | 14 | 76 | 3 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 5.25e-05 | 14 | 76 | 3 | M47384 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.56e-05 | 39 | 76 | 4 | MM14601 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.56e-05 | 39 | 76 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.56e-05 | 39 | 76 | 4 | MM15165 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 5.56e-05 | 39 | 76 | 4 | M39905 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 6.54e-05 | 15 | 76 | 3 | M47382 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 6.54e-05 | 15 | 76 | 3 | M27413 | |
| Pathway | WP_FOCAL_ADHESION | 9.65e-05 | 199 | 76 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 9.65e-05 | 199 | 76 | 7 | M7253 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 9.70e-05 | 17 | 76 | 3 | M212 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 9.70e-05 | 17 | 76 | 3 | M5488 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF597 ZNF20 ZNF23 ZNF175 ZNF558 NR4A2 KMT2A ZNF74 PRKCB ZNF420 PRKCQ ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 NOTCH2 NR1D2 ZNF77 | 1.05e-04 | 1387 | 76 | 19 | M734 |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.07e-04 | 46 | 76 | 4 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.07e-04 | 46 | 76 | 4 | MM1428 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.07e-04 | 46 | 76 | 4 | M46450 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 1.16e-04 | 18 | 76 | 3 | M7552 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 1.16e-04 | 18 | 76 | 3 | MM1479 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.17e-04 | 47 | 76 | 4 | M646 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.20e-04 | 143 | 76 | 6 | M27275 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.23e-04 | 90 | 76 | 5 | MM15882 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.27e-04 | 48 | 76 | 4 | M10775 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.29e-04 | 91 | 76 | 5 | M39426 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 1.37e-04 | 19 | 76 | 3 | M47596 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.61e-04 | 151 | 76 | 6 | M39329 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 1.87e-04 | 21 | 76 | 3 | M47638 | |
| Pathway | PID_NFAT_3PATHWAY | 1.87e-04 | 53 | 76 | 4 | M113 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 2.01e-04 | 54 | 76 | 4 | M17906 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.15e-04 | 22 | 76 | 3 | M27210 | |
| Pathway | PID_TXA2PATHWAY | 2.32e-04 | 56 | 76 | 4 | M99 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 2.47e-04 | 23 | 76 | 3 | MM1470 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 2.81e-04 | 24 | 76 | 3 | M4791 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.84e-04 | 59 | 76 | 4 | M39886 | |
| Pathway | PID_NOTCH_PATHWAY | 2.84e-04 | 59 | 76 | 4 | M17 | |
| Pathway | BIOCARTA_ION_PATHWAY | 2.84e-04 | 5 | 76 | 2 | MM1574 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 2.84e-04 | 5 | 76 | 2 | MM1587 | |
| Pathway | BIOCARTA_ION_PATHWAY | 2.84e-04 | 5 | 76 | 2 | M22059 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 2.84e-04 | 5 | 76 | 2 | M22080 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.01e-04 | 109 | 76 | 5 | MM15164 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 3.56e-04 | 113 | 76 | 5 | M39669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 3.58e-04 | 26 | 76 | 3 | M47557 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 3.65e-04 | 63 | 76 | 4 | M8 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.91e-04 | 250 | 76 | 7 | M27554 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.01e-04 | 27 | 76 | 3 | M39545 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.34e-04 | 118 | 76 | 5 | MM15588 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 4.37e-04 | 66 | 76 | 4 | MM15925 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 4.48e-04 | 28 | 76 | 3 | M252 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 5.45e-04 | 124 | 76 | 5 | M27285 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 5.92e-04 | 7 | 76 | 2 | MM1563 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 5.92e-04 | 7 | 76 | 2 | MM1572 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 5.92e-04 | 7 | 76 | 2 | M22043 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 5.92e-04 | 7 | 76 | 2 | M22057 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 5.92e-04 | 7 | 76 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 6.07e-04 | 31 | 76 | 3 | M47554 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 6.07e-04 | 31 | 76 | 3 | M7223 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 7.10e-04 | 75 | 76 | 4 | M39568 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 7.31e-04 | 33 | 76 | 3 | M39503 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 7.31e-04 | 33 | 76 | 3 | M604 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 7.84e-04 | 77 | 76 | 4 | MM14670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 7.86e-04 | 8 | 76 | 2 | M47850 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 7.99e-04 | 34 | 76 | 3 | M210 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 1.01e-03 | 9 | 76 | 2 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 1.01e-03 | 9 | 76 | 2 | MM1551 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.04e-03 | 83 | 76 | 4 | M39637 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.09e-03 | 84 | 76 | 4 | M7098 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.17e-03 | 147 | 76 | 5 | MM15854 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 1.26e-03 | 10 | 76 | 2 | MM1341 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 1.26e-03 | 10 | 76 | 2 | MM1352 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.32e-03 | 151 | 76 | 5 | M19428 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.39e-03 | 41 | 76 | 3 | M39655 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 1.49e-03 | 42 | 76 | 3 | M16473 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 1.52e-03 | 92 | 76 | 4 | M27322 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 1.52e-03 | 92 | 76 | 4 | M39441 | |
| Pathway | BIOCARTA_CBL_PATHWAY | 1.53e-03 | 11 | 76 | 2 | MM1360 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 1.53e-03 | 11 | 76 | 2 | M10994 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 1.53e-03 | 11 | 76 | 2 | M7014 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 1.53e-03 | 11 | 76 | 2 | M19829 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.53e-03 | 11 | 76 | 2 | M158 | |
| Pathway | WP_CANCER_PATHWAYS | 1.57e-03 | 507 | 76 | 9 | M48302 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 1.59e-03 | 43 | 76 | 3 | M238 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.65e-03 | 94 | 76 | 4 | M1041 | |
| Pubmed | 1.74e-09 | 7 | 94 | 4 | 10433554 | ||
| Pubmed | 3.47e-09 | 8 | 94 | 4 | 14699138 | ||
| Pubmed | 3.47e-09 | 8 | 94 | 4 | 7606770 | ||
| Pubmed | 3.47e-09 | 8 | 94 | 4 | 15894802 | ||
| Pubmed | Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. | 6.24e-09 | 9 | 94 | 4 | 7876252 | |
| Pubmed | 6.24e-09 | 9 | 94 | 4 | 8473314 | ||
| Pubmed | 6.24e-09 | 9 | 94 | 4 | 7850771 | ||
| Pubmed | 6.24e-09 | 9 | 94 | 4 | 8206685 | ||
| Pubmed | FBN1 CRIM1 ADAMTS9 RCBTB1 ATRNL1 SYNE1 EIF4A1 ZNF558 NR4A2 LRP2 ZBTB5 SPARCL1 USP16 LRP1B ZKSCAN5 RPH3A ITGB8 NR1D2 | 9.22e-09 | 1285 | 94 | 18 | 35914814 | |
| Pubmed | 1.04e-08 | 10 | 94 | 4 | 1970444 | ||
| Pubmed | Human immunodeficiency virus induces phosphorylation of its cell surface receptor. | 1.04e-08 | 10 | 94 | 4 | 3259291 | |
| Pubmed | Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates. | 1.04e-08 | 10 | 94 | 4 | 10491200 | |
| Pubmed | 1.04e-08 | 10 | 94 | 4 | 2139676 | ||
| Pubmed | 1.63e-08 | 11 | 94 | 4 | 14613966 | ||
| Pubmed | IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. | 1.63e-08 | 11 | 94 | 4 | 8599832 | |
| Pubmed | Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. | 1.63e-08 | 11 | 94 | 4 | 2182321 | |
| Pubmed | 1.63e-08 | 11 | 94 | 4 | 8914829 | ||
| Pubmed | Expression profile of protein kinase C isozymes in preimplantation mouse development. | 1.63e-08 | 11 | 94 | 4 | 16183862 | |
| Pubmed | 1.87e-08 | 167 | 94 | 8 | 22159717 | ||
| Pubmed | Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. | 1.91e-08 | 3 | 94 | 3 | 9814702 | |
| Pubmed | Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice. | 1.91e-08 | 3 | 94 | 3 | 7760054 | |
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 22819675 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 3755548 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 1714454 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 19895572 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 19556521 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 27307229 | ||
| Pubmed | 2.44e-08 | 12 | 94 | 4 | 11919157 | ||
| Pubmed | Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium. | 2.44e-08 | 12 | 94 | 4 | 11141237 | |
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 2.44e-08 | 12 | 94 | 4 | 18577246 | |
| Pubmed | 2.44e-08 | 12 | 94 | 4 | 19363595 | ||
| Pubmed | HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system. | 3.51e-08 | 13 | 94 | 4 | 10641798 | |
| Pubmed | 3.51e-08 | 13 | 94 | 4 | 8948582 | ||
| Pubmed | 4.12e-08 | 71 | 94 | 6 | 33541421 | ||
| Pubmed | HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. | 4.91e-08 | 14 | 94 | 4 | 7642615 | |
| Pubmed | 6.68e-08 | 15 | 94 | 4 | 8627654 | ||
| Pubmed | HIV envelope gp120 activates human arterial smooth muscle cells. | 6.68e-08 | 15 | 94 | 4 | 11504923 | |
| Pubmed | Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain. | 7.63e-08 | 4 | 94 | 3 | 9244383 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 9694886 | ||
| Pubmed | Characterization of a 7.5-kDa protein kinase C substrate (RC3 protein, neurogranin) from rat brain. | 7.63e-08 | 4 | 94 | 3 | 8080473 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 10871288 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 8631738 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 7499337 | ||
| Pubmed | Regulation of ARNO nucleotide exchange by a PH domain electrostatic switch. | 7.63e-08 | 4 | 94 | 3 | 10531036 | |
| Pubmed | Protein kinase C phosphorylation of syntaxin 4 in thrombin-activated human platelets. | 7.63e-08 | 4 | 94 | 3 | 10856305 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 15367584 | ||
| Pubmed | Physiological regulation of Munc18/nSec1 phosphorylation on serine-313. | 7.63e-08 | 4 | 94 | 3 | 12950453 | |
| Pubmed | Presynaptic Short-Term Plasticity Persists in the Absence of PKC Phosphorylation of Munc18-1. | 7.63e-08 | 4 | 94 | 3 | 34290081 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 8662663 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 11063746 | ||
| Pubmed | ADAMTS10 ADSS2 EIF4A1 LRP2 UBA6 KMT2A PRKCA PRKCB PRKCG PRKCQ ADAM12 LRP1B LDLR | 8.73e-08 | 730 | 94 | 13 | 34857952 | |
| Pubmed | 8.88e-08 | 16 | 94 | 4 | 11833470 | ||
| Pubmed | 8.88e-08 | 16 | 94 | 4 | 1832084 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 7513693 | ||
| Pubmed | Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. | 1.90e-07 | 5 | 94 | 3 | 11123317 | |
| Pubmed | Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin. | 1.90e-07 | 5 | 94 | 3 | 9030777 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 12569090 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 2590242 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 30013171 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 28228266 | ||
| Pubmed | Protein kinase C regulates the phosphorylation and cellular localization of occludin. | 1.90e-07 | 5 | 94 | 3 | 11502742 | |
| Pubmed | Regulation of the ErbB3 binding protein Ebp1 by protein kinase C. | 1.90e-07 | 5 | 94 | 3 | 11325528 | |
| Pubmed | Protein kinase C activity regulates the onset of anaphase I in mouse oocytes. | 1.90e-07 | 5 | 94 | 3 | 15229137 | |
| Pubmed | PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control. | 1.90e-07 | 5 | 94 | 3 | 23824069 | |
| Pubmed | Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis. | 1.90e-07 | 5 | 94 | 3 | 12519779 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 20392936 | ||
| Pubmed | 2.35e-07 | 20 | 94 | 4 | 11044099 | ||
| Pubmed | 2.89e-07 | 21 | 94 | 4 | 9446795 | ||
| Pubmed | 2.89e-07 | 21 | 94 | 4 | 22114277 | ||
| Pubmed | 2.89e-07 | 21 | 94 | 4 | 9671211 | ||
| Pubmed | 3.53e-07 | 22 | 94 | 4 | 9151826 | ||
| Pubmed | 3.53e-07 | 22 | 94 | 4 | 11154208 | ||
| Pubmed | Specific protein kinase C isoforms are required for rod photoreceptor differentiation. | 3.80e-07 | 6 | 94 | 3 | 22171059 | |
| Pubmed | Protein kinase C isoform expression and activity in the mouse heart. | 3.80e-07 | 6 | 94 | 3 | 11668067 | |
| Pubmed | Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. | 3.80e-07 | 6 | 94 | 3 | 11306676 | |
| Pubmed | Protein kinase C-theta is specifically localized on centrosomes and kinetochores in mitotic cells. | 3.80e-07 | 6 | 94 | 3 | 9854032 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 8940188 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 24863469 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 10879655 | ||
| Pubmed | The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. | 3.80e-07 | 6 | 94 | 3 | 12093536 | |
| Pubmed | An immunohistochemical study of protein kinase C distribution in fetal mouse vertebral column. | 3.80e-07 | 6 | 94 | 3 | 7985811 | |
| Pubmed | PKCε Inhibits Neuronal Dendritic Spine Development through Dual Phosphorylation of Ephexin5. | 3.80e-07 | 6 | 94 | 3 | 30485813 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.92e-07 | 248 | 94 | 8 | 24006456 | |
| Pubmed | 5.10e-07 | 24 | 94 | 4 | 10843712 | ||
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 6.06e-07 | 25 | 94 | 4 | 15689238 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 12147342 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 7588787 | ||
| Pubmed | Functional association of cytokine-induced SH2 protein and protein kinase C in activated T cells. | 6.64e-07 | 7 | 94 | 3 | 12618484 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 15381704 | ||
| Pubmed | Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. | 6.64e-07 | 7 | 94 | 3 | 12958364 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 22265677 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 22114345 | ||
| Pubmed | Activation of annexin 7 by protein kinase C in vitro and in vivo. | 6.64e-07 | 7 | 94 | 3 | 11278415 | |
| Pubmed | 8.37e-07 | 27 | 94 | 4 | 20336759 | ||
| Pubmed | 8.37e-07 | 27 | 94 | 4 | 21651489 | ||
| Pubmed | 8.57e-07 | 118 | 94 | 6 | 21078624 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 8922669 | ||
| Pubmed | PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments. | 1.06e-06 | 8 | 94 | 3 | 12134071 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.06e-06 | 8 | 94 | 3 | 22652674 | |
| Pubmed | Glycogen synthase kinase-3: properties, functions, and regulation. | 1.06e-06 | 8 | 94 | 3 | 11749387 | |
| Interaction | NTN5 interactions | 9.57e-14 | 24 | 92 | 8 | int:NTN5 | |
| Interaction | ZFP41 interactions | 1.90e-10 | 57 | 92 | 8 | int:ZFP41 | |
| Interaction | IGFL3 interactions | 1.82e-09 | 75 | 92 | 8 | int:IGFL3 | |
| Interaction | EGFL6 interactions | 2.29e-06 | 21 | 92 | 4 | int:EGFL6 | |
| Interaction | CASR interactions | 2.79e-06 | 22 | 92 | 4 | int:CASR | |
| Interaction | MFAP5 interactions | 3.90e-06 | 52 | 92 | 5 | int:MFAP5 | |
| Interaction | ZNF408 interactions | 4.54e-06 | 145 | 92 | 7 | int:ZNF408 | |
| Interaction | ST14 interactions | 4.81e-06 | 207 | 92 | 8 | int:ST14 | |
| Interaction | ZNF517 interactions | 8.85e-06 | 29 | 92 | 4 | int:ZNF517 | |
| Interaction | VWCE interactions | 1.10e-05 | 64 | 92 | 5 | int:VWCE | |
| Interaction | ZDHHC15 interactions | 2.33e-05 | 125 | 92 | 6 | int:ZDHHC15 | |
| Interaction | GREM2 interactions | 2.39e-05 | 37 | 92 | 4 | int:GREM2 | |
| Interaction | TAFA3 interactions | 2.88e-05 | 78 | 92 | 5 | int:TAFA3 | |
| Interaction | GRM5 interactions | 4.38e-05 | 43 | 92 | 4 | int:GRM5 | |
| Interaction | DEFB123 interactions | 4.94e-05 | 16 | 92 | 3 | int:DEFB123 | |
| Interaction | SLURP1 interactions | 5.16e-05 | 144 | 92 | 6 | int:SLURP1 | |
| Interaction | TIMP3 interactions | 5.75e-05 | 90 | 92 | 5 | int:TIMP3 | |
| Interaction | LTBP1 interactions | 6.39e-05 | 92 | 92 | 5 | int:LTBP1 | |
| Interaction | CHAT interactions | 7.15e-05 | 18 | 92 | 3 | int:CHAT | |
| Interaction | FOXD4L6 interactions | 7.36e-05 | 49 | 92 | 4 | int:FOXD4L6 | |
| Interaction | CCN6 interactions | 8.46e-05 | 19 | 92 | 3 | int:CCN6 | |
| Interaction | NRGN interactions | 8.46e-05 | 19 | 92 | 3 | int:NRGN | |
| Interaction | ZNF224 interactions | 9.92e-05 | 20 | 92 | 3 | int:ZNF224 | |
| Interaction | NOTCH2 interactions | 1.36e-04 | 423 | 92 | 9 | int:NOTCH2 | |
| Interaction | EDN3 interactions | 1.37e-04 | 108 | 92 | 5 | int:EDN3 | |
| Interaction | ATXN7 interactions | 1.43e-04 | 109 | 92 | 5 | int:ATXN7 | |
| Interaction | LAMA2 interactions | 1.53e-04 | 23 | 92 | 3 | int:LAMA2 | |
| Interaction | NOTCH3 interactions | 1.69e-04 | 113 | 92 | 5 | int:NOTCH3 | |
| Interaction | LIPG interactions | 2.10e-04 | 64 | 92 | 4 | int:LIPG | |
| Interaction | ATN1 interactions | 2.17e-04 | 187 | 92 | 6 | int:ATN1 | |
| Interaction | HOXA1 interactions | 2.25e-04 | 356 | 92 | 8 | int:HOXA1 | |
| Interaction | FBLN2 interactions | 2.36e-04 | 66 | 92 | 4 | int:FBLN2 | |
| Interaction | LTBP4 interactions | 2.50e-04 | 67 | 92 | 4 | int:LTBP4 | |
| Interaction | FEZF1 interactions | 2.78e-04 | 28 | 92 | 3 | int:FEZF1 | |
| Interaction | ADAMTS9 interactions | 3.06e-04 | 6 | 92 | 2 | int:ADAMTS9 | |
| Interaction | TIAM2 interactions | 3.09e-04 | 29 | 92 | 3 | int:TIAM2 | |
| Interaction | LDB3 interactions | 3.09e-04 | 29 | 92 | 3 | int:LDB3 | |
| Interaction | CD5 interactions | 3.42e-04 | 30 | 92 | 3 | int:CD5 | |
| Interaction | KRTAP10-7 interactions | 3.90e-04 | 293 | 92 | 7 | int:KRTAP10-7 | |
| Interaction | SHANK3 interactions | 4.38e-04 | 496 | 92 | 9 | int:SHANK3 | |
| Cytoband | 19p13.2 | 8.14e-06 | 229 | 94 | 6 | 19p13.2 | |
| Cytoband | 13q14 | 1.02e-03 | 23 | 94 | 2 | 13q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.28e-03 | 797 | 94 | 7 | chr19p13 | |
| Cytoband | 17p13 | 2.23e-03 | 34 | 94 | 2 | 17p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.31e-03 | 127 | 94 | 3 | chr2q24 | |
| Cytoband | 7q22 | 2.78e-03 | 38 | 94 | 2 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 3.14e-03 | 1192 | 94 | 8 | chr19q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 ZNF20 ZNF23 ZNF728 ZNF175 ZFP64 ZNF780B ZNF558 ZBTB5 ZNF74 ZNF420 ZNF761 ZNF418 ZKSCAN5 ZNF433 ZNF169 ZNF77 | 8.18e-09 | 718 | 78 | 17 | 28 |
| GeneFamily | C2 domain containing protein kinases | 6.60e-08 | 10 | 78 | 4 | 835 | |
| GeneFamily | Low density lipoprotein receptors | 2.14e-05 | 13 | 78 | 3 | 634 | |
| GeneFamily | Ubiquitin specific peptidases | 9.93e-05 | 56 | 78 | 4 | 366 | |
| GeneFamily | Netrins | 2.73e-04 | 6 | 78 | 2 | 661 | |
| GeneFamily | CD molecules|Integrin beta subunits | 6.49e-04 | 9 | 78 | 2 | 1159 | |
| GeneFamily | Laminin subunits | 1.18e-03 | 12 | 78 | 2 | 626 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.00e-03 | 19 | 78 | 2 | 50 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.01e-03 | 27 | 78 | 2 | 47 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.05e-09 | 196 | 93 | 10 | M3008 | |
| Coexpression | NABA_MATRISOME | ADAMTS10 FBLN1 IL17A FBN1 CRIM1 ADAMTS9 NTN3 WNT11 LAMA2 LAMB2 NTN1 LTBP1 SPARCL1 ADAMTSL3 ADAM12 ADAM10 MUC2 USH2A | 1.83e-08 | 1026 | 93 | 18 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.72e-08 | 191 | 93 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 5.16e-08 | 275 | 93 | 10 | M5884 | |
| Coexpression | NABA_MATRISOME | ADAMTS10 FBLN1 IL17A FBN1 CRIM1 ADAMTS9 NTN3 WNT11 LAMA2 LAMB2 NTN1 LTBP1 SPARCL1 ADAMTSL3 ADAM12 ADAM10 MUC2 | 8.47e-08 | 1008 | 93 | 17 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.01e-07 | 40 | 93 | 5 | M5887 | |
| Coexpression | NABA_CORE_MATRISOME | 5.17e-07 | 270 | 93 | 9 | MM17057 | |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 7.14e-06 | 199 | 93 | 7 | M7619 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 1.27e-05 | 144 | 93 | 6 | M5942 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_DN | 7.82e-05 | 199 | 93 | 6 | M8405 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 7.82e-05 | 199 | 93 | 6 | M5219 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | 7.82e-05 | 199 | 93 | 6 | M8770 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TCONV_DN | 8.04e-05 | 200 | 93 | 6 | M5750 | |
| Coexpression | HU_FETAL_RETINA_RPE | 8.11e-05 | 291 | 93 | 7 | M39271 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.30e-04 | 137 | 93 | 5 | M40313 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 1.41e-04 | 546 | 93 | 9 | M3837 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-09 | 194 | 94 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-09 | 194 | 94 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-09 | 195 | 94 | 8 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-09 | 196 | 94 | 8 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-09 | 196 | 94 | 8 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-09 | 196 | 94 | 8 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.08e-09 | 196 | 94 | 8 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.45e-09 | 197 | 94 | 8 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.45e-09 | 197 | 94 | 8 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.45e-09 | 197 | 94 | 8 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.06e-08 | 200 | 94 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-07 | 183 | 94 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 190 | 94 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 190 | 94 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.73e-07 | 192 | 94 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-07 | 193 | 94 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-07 | 195 | 94 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-07 | 195 | 94 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-07 | 195 | 94 | 7 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 196 | 94 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 196 | 94 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-07 | 200 | 94 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-07 | 200 | 94 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-06 | 88 | 94 | 5 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 170 | 94 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-06 | 176 | 94 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.01e-06 | 176 | 94 | 6 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-06 | 176 | 94 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-06 | 182 | 94 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-06 | 182 | 94 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-06 | 183 | 94 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-06 | 183 | 94 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 184 | 94 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-06 | 184 | 94 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-06 | 185 | 94 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.69e-06 | 185 | 94 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-06 | 185 | 94 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-06 | 188 | 94 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.95e-06 | 188 | 94 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 188 | 94 | 6 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 188 | 94 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.04e-06 | 189 | 94 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 189 | 94 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 190 | 94 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.13e-06 | 190 | 94 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 190 | 94 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 191 | 94 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 191 | 94 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 191 | 94 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.23e-06 | 191 | 94 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 191 | 94 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 191 | 94 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.23e-06 | 191 | 94 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 192 | 94 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 192 | 94 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 192 | 94 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 192 | 94 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 192 | 94 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.33e-06 | 192 | 94 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 192 | 94 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-06 | 192 | 94 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 3.33e-06 | 192 | 94 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 3.33e-06 | 192 | 94 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 193 | 94 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 193 | 94 | 6 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 193 | 94 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 193 | 94 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 193 | 94 | 6 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.43e-06 | 193 | 94 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.43e-06 | 193 | 94 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.43e-06 | 193 | 94 | 6 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 193 | 94 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-06 | 193 | 94 | 6 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-06 | 193 | 94 | 6 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 194 | 94 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-06 | 195 | 94 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 195 | 94 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 195 | 94 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 195 | 94 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 195 | 94 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 195 | 94 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-06 | 195 | 94 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.64e-06 | 195 | 94 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 196 | 94 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 196 | 94 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.75e-06 | 196 | 94 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 196 | 94 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 196 | 94 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 196 | 94 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-06 | 196 | 94 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 197 | 94 | 6 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 197 | 94 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 197 | 94 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 197 | 94 | 6 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 197 | 94 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 198 | 94 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 3.97e-06 | 198 | 94 | 6 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| Computational | Genes in the cancer module 248. | 7.12e-05 | 129 | 59 | 6 | MODULE_248 | |
| Drug | antibiotic from Streptomyces | 1.61e-08 | 42 | 91 | 6 | CID000005153 | |
| Drug | AC1L1B58 | 1.00e-07 | 29 | 91 | 5 | CID000001288 | |
| Drug | daphnetoxin | 2.46e-07 | 4 | 91 | 3 | CID000119454 | |
| Drug | RK-1409B | 3.15e-07 | 15 | 91 | 4 | CID003036125 | |
| Drug | dansyl-DAG | 3.15e-07 | 15 | 91 | 4 | CID000129493 | |
| Drug | AC1L1JQC | 5.46e-07 | 17 | 91 | 4 | CID000005157 | |
| Drug | daphnoretin | 5.46e-07 | 17 | 91 | 4 | CID005281406 | |
| Drug | dihydrosterculic acid | 7.00e-07 | 18 | 91 | 4 | CID000160788 | |
| Drug | TAPP-Br | 8.84e-07 | 19 | 91 | 4 | CID000160326 | |
| Drug | KS-619-1 | 1.36e-06 | 21 | 91 | 4 | CID000128369 | |
| Drug | K-259-2 | 1.36e-06 | 21 | 91 | 4 | CID006438946 | |
| Drug | broussochalcone A | 1.36e-06 | 21 | 91 | 4 | CID006438825 | |
| Drug | pseudohypericin | 3.91e-06 | 27 | 91 | 4 | CID005281751 | |
| Drug | aplysiatoxin | 4.54e-06 | 28 | 91 | 4 | CID000040465 | |
| Drug | Polychlorinated biphenyls | 5.25e-06 | 29 | 91 | 4 | CID000006636 | |
| Drug | monatepil | 5.25e-06 | 29 | 91 | 4 | CID000060810 | |
| Drug | AC1L1FGW | 8.94e-06 | 33 | 91 | 4 | CID000003231 | |
| Drug | bupivacaine | 1.10e-05 | 125 | 91 | 6 | CID000002474 | |
| Drug | bryostatin 1 | 1.32e-05 | 12 | 91 | 3 | ctd:C046785 | |
| Drug | norathyriol | 1.43e-05 | 37 | 91 | 4 | CID005281656 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.43e-05 | 197 | 91 | 7 | 2703_UP | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 1.43e-05 | 197 | 91 | 7 | 6703_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 91 | 7 | 5680_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 91 | 7 | 2319_UP | |
| Drug | 12-hydroxydaphnetoxin | 1.58e-05 | 2 | 91 | 2 | CID000099841 | |
| Drug | Ro 31-7549 | 1.76e-05 | 39 | 91 | 4 | CID000002403 | |
| Drug | digoxigenine | 1.95e-05 | 40 | 91 | 4 | CID000015478 | |
| Drug | acetyl-L-carnitine | 2.20e-05 | 84 | 91 | 5 | CID000000001 | |
| Drug | benzenesulfonate | 2.38e-05 | 42 | 91 | 4 | CID000007371 | |
| Drug | pinacidil | 2.60e-05 | 87 | 91 | 5 | CID000004826 | |
| Drug | SC-9 | 2.62e-05 | 43 | 91 | 4 | CID000124172 | |
| Drug | benzoyl | 2.62e-05 | 43 | 91 | 4 | CID000007187 | |
| Drug | AC1LDMDX | 2.62e-05 | 43 | 91 | 4 | CID000621355 | |
| Drug | dihydrosphingosine | 2.67e-05 | 146 | 91 | 6 | CID000003126 | |
| Drug | 1-stearoyl-2-arachidonylglycerol | 2.71e-05 | 15 | 91 | 3 | CID006443869 | |
| Drug | tetracaine | 2.75e-05 | 88 | 91 | 5 | CID000005411 | |
| Drug | eicosa-8,11,14-trienoic acid | 2.75e-05 | 88 | 91 | 5 | CID000003011 | |
| Drug | barium | 2.88e-05 | 148 | 91 | 6 | CID000104810 | |
| Drug | H-9 dihydrochloride | 3.07e-05 | 90 | 91 | 5 | CID000003544 | |
| Drug | procyanidin B2 | 3.14e-05 | 45 | 91 | 4 | CID000122738 | |
| Drug | myricitrin | 3.14e-05 | 45 | 91 | 4 | CID005281673 | |
| Drug | sodium dodecyl sulfate | 3.24e-05 | 91 | 91 | 5 | CID000008778 | |
| Drug | tocopherol | 3.24e-05 | 91 | 91 | 5 | CID000014986 | |
| Drug | tert-Butyl Alcohol | 3.33e-05 | 16 | 91 | 3 | ctd:D020002 | |
| Drug | NPC 15437 | 3.43e-05 | 46 | 91 | 4 | CID000004548 | |
| Drug | triphenylethylene | 3.43e-05 | 46 | 91 | 4 | CID000006025 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.74e-05 | 155 | 91 | 6 | 6817_DN | |
| Drug | 1,3-DCG | 3.79e-05 | 94 | 91 | 5 | CID000150911 | |
| Drug | I-Q-S | 3.88e-05 | 156 | 91 | 6 | CID000003540 | |
| Drug | phorbol 12,13-diacetate | 4.06e-05 | 48 | 91 | 4 | CID000072293 | |
| Drug | 1,2-dicaprin | 4.41e-05 | 49 | 91 | 4 | CID000001321 | |
| Drug | NSC150531 | 4.41e-05 | 49 | 91 | 4 | CID000004475 | |
| Drug | thiamylal | 4.41e-05 | 49 | 91 | 4 | CID003032285 | |
| Drug | octahydromezerein | 4.73e-05 | 3 | 91 | 2 | CID000164152 | |
| Drug | AC1L1GUQ | 4.78e-05 | 50 | 91 | 4 | CID000003849 | |
| Drug | (S)-1,2-Diolein | 4.78e-05 | 50 | 91 | 4 | CID000001324 | |
| Drug | thiomalate | 4.78e-05 | 50 | 91 | 4 | CID000006268 | |
| Drug | Trimethyltin ion | 4.78e-05 | 50 | 91 | 4 | CID000021162 | |
| Drug | dipalmitin | 4.83e-05 | 18 | 91 | 3 | CID000068149 | |
| Drug | Cgp-42700 | 4.83e-05 | 18 | 91 | 3 | CID000188390 | |
| Drug | mepivacaine | 5.17e-05 | 51 | 91 | 4 | CID000004062 | |
| Drug | N-desmethyl-tamoxifen-hydrochloride | 5.58e-05 | 52 | 91 | 4 | CID000035887 | |
| Drug | auranofin | 5.58e-05 | 52 | 91 | 4 | CID006918453 | |
| Drug | sapintoxin A | 5.71e-05 | 19 | 91 | 3 | CID000108085 | |
| Drug | 4 alpha-phorbol | 5.87e-05 | 103 | 91 | 5 | CID000028683 | |
| Drug | Deltorphin Ii | 6.48e-05 | 54 | 91 | 4 | CID000123795 | |
| Drug | CGP 19835A | 6.48e-05 | 54 | 91 | 4 | CID005479141 | |
| Drug | phosphine oxide | 7.04e-05 | 107 | 91 | 5 | CID000166931 | |
| Drug | AC1L63MU | 7.60e-05 | 347 | 91 | 8 | CID000285703 | |
| Drug | MDL 27,032 | 7.80e-05 | 21 | 91 | 3 | CID000163812 | |
| Drug | 2-octanol | 7.80e-05 | 21 | 91 | 3 | CID000020083 | |
| Drug | debromoaplysiatoxin | 7.80e-05 | 21 | 91 | 3 | CID000002967 | |
| Drug | ALT-711 | 7.80e-05 | 21 | 91 | 3 | CID000216304 | |
| Drug | glutathionyl 4-hydroxy-2-nonenal conjugate | 9.43e-05 | 4 | 91 | 2 | ctd:C524061 | |
| Drug | L-alpha-lecithin | 9.81e-05 | 60 | 91 | 4 | CID000122218 | |
| Drug | midostaurin | 9.91e-05 | 115 | 91 | 5 | ctd:C059539 | |
| Drug | AC1L4NFY | 1.03e-04 | 23 | 91 | 3 | CID000160335 | |
| Drug | mangrove | 1.07e-04 | 468 | 91 | 9 | CID000000965 | |
| Drug | Russian VX | 1.12e-04 | 62 | 91 | 4 | CID000178033 | |
| Drug | myristyl acetate | 1.19e-04 | 63 | 91 | 4 | CID000012531 | |
| Drug | puerarin | 1.19e-04 | 63 | 91 | 4 | CID005281807 | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.26e-04 | 193 | 91 | 6 | 2852_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 194 | 91 | 6 | 2789_UP | |
| Drug | Calpain inhibitor I | 1.32e-04 | 280 | 91 | 7 | CID000004332 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A | 1.33e-04 | 195 | 91 | 6 | 4467_UP | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.33e-04 | 195 | 91 | 6 | 5744_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HG-U133A | 1.37e-04 | 196 | 91 | 6 | 492_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 3896_UP | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 2295_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 2641_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 3978_UP | |
| Drug | ethoxytriethyleneglycol | 1.42e-04 | 66 | 91 | 4 | CID000008190 | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 6079_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 4323_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 1.45e-04 | 198 | 91 | 6 | 1042_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 3140_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 7552_DN | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 3580_UP | |
| Drug | 12-deoxyphorbolphenylacetate-20-acetate | 1.57e-04 | 5 | 91 | 2 | ctd:C029705 | |
| Drug | 3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol | 1.57e-04 | 5 | 91 | 2 | ctd:C500067 | |
| Disease | Schizophrenia | JAG2 ADSS2 RCBTB1 KCNJ3 NR4A2 LRP2 LAMA2 KMT2A ZNF74 PRKCA ADAMTSL3 ADAM12 RASD2 | 2.14e-06 | 883 | 88 | 13 | C0036341 |
| Disease | type 1 diabetes mellitus | 8.26e-06 | 242 | 88 | 7 | MONDO_0005147 | |
| Disease | Weill-Marchesani syndrome | 2.63e-05 | 3 | 88 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 2.63e-05 | 3 | 88 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 2.63e-05 | 3 | 88 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 5.26e-05 | 4 | 88 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 5.26e-05 | 4 | 88 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 8.74e-05 | 5 | 88 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | Endometrioma | 1.24e-04 | 161 | 88 | 5 | C0269102 | |
| Disease | Endometriosis | 1.24e-04 | 161 | 88 | 5 | C0014175 | |
| Disease | Stage IV Skin Melanoma | 1.83e-04 | 7 | 88 | 2 | C1321872 | |
| Disease | Glioblastoma Multiforme | 3.47e-04 | 111 | 88 | 4 | C1621958 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 4.81e-04 | 51 | 88 | 3 | EFO_0022285 | |
| Disease | Intestinal Neoplasms | 5.69e-04 | 12 | 88 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 5.69e-04 | 12 | 88 | 2 | C0346627 | |
| Disease | extrapulmonary tuberculosis | 5.69e-04 | 12 | 88 | 2 | MONDO_0000368 | |
| Disease | mood disorder | 6.71e-04 | 13 | 88 | 2 | EFO_0004247 | |
| Disease | rostral middle frontal gyrus volume measurement | 7.82e-04 | 14 | 88 | 2 | EFO_0010328 | |
| Disease | respiratory system disease | 9.47e-04 | 145 | 88 | 4 | EFO_0000684 | |
| Disease | cognitive function measurement | ARAP3 THSD7A CRIM1 KCNJ3 CD163L1 MACROD2 LTBP1 ADAMTSL3 MUC2 USH2A LRP1B NR1D2 | 1.11e-03 | 1434 | 88 | 12 | EFO_0008354 |
| Disease | muscular dystrophy (is_implicated_in) | 1.16e-03 | 17 | 88 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.16e-03 | 69 | 88 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | glaucoma | 1.18e-03 | 154 | 88 | 4 | MONDO_0005041 | |
| Disease | Colorectal Carcinoma | 1.19e-03 | 702 | 88 | 8 | C0009402 | |
| Disease | ischemia (biomarker_via_orthology) | 1.30e-03 | 18 | 88 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | juvenile idiopathic arthritis | 1.43e-03 | 74 | 88 | 3 | EFO_0002609 | |
| Disease | sphingomyelin measurement | 1.48e-03 | 278 | 88 | 5 | EFO_0010118 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.61e-03 | 20 | 88 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | cortical thickness | JAG2 FBN1 CRIM1 ADAMTS9 MACROD2 LAMA2 KMT2A ADAMTSL3 ADAM12 ADAM10 | 1.76e-03 | 1113 | 88 | 10 | EFO_0004840 |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 1.95e-03 | 22 | 88 | 2 | EFO_0021115 | |
| Disease | QRS duration | 2.01e-03 | 298 | 88 | 5 | EFO_0005055 | |
| Disease | information processing speed | 2.12e-03 | 85 | 88 | 3 | EFO_0004363 | |
| Disease | cortical surface area measurement | JAG2 FBN1 ZAN USP38 ADAMTS9 MACROD2 LAMA2 NTN1 ADAMTSL3 ADAM12 ITGB8 | 2.17e-03 | 1345 | 88 | 11 | EFO_0010736 |
| Disease | macula measurement | 2.50e-03 | 189 | 88 | 4 | EFO_0008375 | |
| Disease | body composition measurement | 2.70e-03 | 193 | 88 | 4 | EFO_0005106 | |
| Disease | refractive error, age at onset, Myopia | 2.70e-03 | 193 | 88 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 2.73e-03 | 26 | 88 | 2 | EFO_0009944 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.80e-03 | 195 | 88 | 4 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVICKQCAGQHRALG | 521 | Q8WWN8 | |
| GHSIRQIVQGCNILC | 406 | Q9NQI0 | |
| NRHTQVCINGQCAGS | 556 | O14672 | |
| AMQCHGRGVCNNRKN | 661 | O43184 | |
| CINNIQHTGECAVGL | 286 | B6SEH9 | |
| ARQGHTKVVNCLIGC | 586 | Q9ULJ7 | |
| HVVCQKLGCGVAFNA | 1071 | Q9NR16 | |
| VQNNLCFGKCGSVHF | 181 | O95813 | |
| DEQCRFQHGVKSRQC | 476 | Q9H324 | |
| RTGNTQQKVCKQCHE | 116 | Q96K21 | |
| VSDLQVGGRCKCNGH | 276 | O95631 | |
| NCLHIKRVVGIACGQ | 176 | Q8NDN9 | |
| KRIGQGILCIDNVHC | 141 | Q6NSI4 | |
| CQNGGTCIDLVNHFK | 1196 | Q04721 | |
| HRCQTKVANLCGINQ | 271 | Q04759 | |
| GTNKCVHLSQLCNGV | 86 | Q9NZR2 | |
| AKKGTHFVQLCCQRN | 381 | Q9HCC0 | |
| RGQCQHGGTCKDLVN | 466 | Q9Y219 | |
| CINNIQHTGECAVGL | 286 | B6SEH8 | |
| CHACIGGTNVRAEVQ | 131 | P60842 | |
| VGAVCCRVDHSQNQK | 56 | Q9GZZ1 | |
| NFSCVRHKGLLCGGN | 541 | P18564 | |
| QQLQGVNVCGGRCCH | 161 | Q14766 | |
| HGQKVQCDVSVGFIC | 1351 | Q02817 | |
| LDGLNCRQCGVQHVK | 261 | Q9UBY5 | |
| KEHVVGTRCQQCRDG | 441 | P55268 | |
| HSQTGQCECRANVQG | 931 | P24043 | |
| GKQGFQCQVCCFVVH | 61 | P05771 | |
| KQGLQCQVCSFVVHR | 61 | P05129 | |
| NNGGCEQVCVLSHRT | 666 | P98164 | |
| EAKCRHLGCINADGN | 91 | Q16552 | |
| ATDLQVGGRCKCNGH | 246 | O00634 | |
| HCCLLGRAAQAQGQS | 111 | P23142 | |
| QHCVNSKGQVCSGRG | 591 | P26012 | |
| QGVRCSDCGLNVHKQ | 241 | P52757 | |
| GFRLQINAQNCVHCK | 576 | Q16134 | |
| QGLCRQAGCDHVLNS | 721 | Q9P2N4 | |
| VCNAGFHVTRDGKNC | 556 | P35555 | |
| TKQHNCQFLCVNTIG | 2491 | P35555 | |
| GVILCGLTHKQAVQC | 16 | Q6IN97 | |
| ECINFIHCCRLNGGN | 66 | Q9H1R2 | |
| DCINGFKRDHNGCRT | 481 | Q9NZV1 | |
| VGDQCQHCQGRFKLT | 86 | Q5VV63 | |
| CAGHDRCKQALLQIG | 31 | Q1MX18 | |
| FCHVCGRQHQATKQL | 1481 | Q03164 | |
| QCFDRCHRLGQKQEV | 941 | Q14527 | |
| KKCQVERQEGHSQGF | 41 | Q86SQ9 | |
| CSESQQHLNGQFKGR | 311 | Q14995 | |
| ECRNLNGCDTGHAKI | 116 | A1Z1Q3 | |
| IVNCLKDHVTFNNGG | 531 | P43354 | |
| DQIGGQCNCKRHVSG | 656 | O75445 | |
| RHVSGRQCNQCQNGF | 666 | O75445 | |
| TVQARCLFGNQICGE | 2096 | Q92673 | |
| KQALVFQCVGCGAFH | 341 | Q9NXH9 | |
| NVCTKCGVETNNRLH | 121 | Q9Y2J0 | |
| TCRKQDGGQAGIHEC | 871 | Q9UPZ6 | |
| KRLIHENQGQCCGLI | 2071 | Q8NF91 | |
| RKTECHCQIVNLGAG | 86 | Q9UIC8 | |
| GKQGFQCQVCCFVVH | 61 | P17252 | |
| IVCRCQGGNNAGHTV | 56 | P30520 | |
| QKIQSGHSLEGCFQV | 671 | A0AVT1 | |
| TKEGNVGRFLNHSCC | 641 | Q96T68 | |
| NHCNCIIDQIFTGGL | 291 | Q9UPT9 | |
| QLGRLCESNEGHQCG | 106 | Q15935 | |
| GQLCDCVIVVGNRHF | 21 | O15062 | |
| VCGKLFNQKRNLACH | 246 | Q86XN6 | |
| QCGKGFRCASQLQIH | 371 | P17024 | |
| KCGHQGCGRNSQEQH | 76 | Q9Y5T5 | |
| ICCAQVLQGHKTFLN | 626 | Q9UMS5 | |
| QIEKICGFQIAHNSG | 436 | Q9P246 | |
| QLDQTGQHLFCVCGT | 31 | Q12788 | |
| GQHLFCVCGTRVNIL | 36 | Q12788 | |
| FQCKRGHICKADQQG | 436 | Q14515 | |
| HRGVKLNECNQCFKV | 146 | Q96NG5 | |
| CGHENLQLKIGCTNV | 106 | P0DKX0 | |
| VICGNKNDHGELCRQ | 136 | Q96D21 | |
| CGKAFNRGSNLVQHQ | 506 | Q9Y6R6 | |
| TFCQQLVRTIGHFQC | 166 | Q8NB14 | |
| NEKVGSHGTQDRQCN | 286 | O96014 | |
| ECGKCFTQKGNLIQH | 346 | Q8TF45 | |
| RCGECGKAFNQRTHL | 361 | Q16587 | |
| ECGKAFICGSQLSQH | 311 | Q8TAQ5 | |
| QGRHKCIENVSRQNC | 131 | Q96PM5 | |
| CGDCGKIFNHRANLR | 186 | Q96LX8 | |
| CGKGFRCSSQLRQHQ | 341 | P17027 | |
| CGKVFRCSSQLQVHG | 651 | Q8N7K0 | |
| HICGICKQQFNNLDA | 31 | Q9NTW7 | |
| FHGQLRSQVKCKTCG | 681 | P35125 | |
| CGRGFCQKASLLQHQ | 351 | Q14929 | |
| HTGETFCKGNQCRKV | 246 | Q9Y473 | |
| CGECGKSYNQRVHLT | 376 | Q9Y2L8 | |
| IHAQNGRKCQYVGNC | 761 | Q9UGR2 | |
| QCGTHTVCQLKNGQY | 1131 | Q9Y493 | |
| CALKCHAQGQNLVVE | 161 | P82987 | |
| FVDKNGRCNVQHGNL | 46 | P48549 | |
| NNGGCSHVCNDLKIG | 321 | P01130 | |
| EHKGCQRILFINNCQ | 301 | Q00872 |